<main class="publication" lang="en" role="main">
      



<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

<div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
      <span class="govuk-caption-xl gem-c-title__context">
    Decision
  </span>


  <h1 class="gem-c-title__text govuk-heading-l">
    Regulatory approval of COVID-19 Vaccine AstraZeneca
  </h1>
</div>
  </div>
  

  <div class="govuk-grid-column-two-thirds">
      <p class="gem-c-lead-paragraph">Information for healthcare professionals and the public about COVID-19 Vaccine AstraZeneca.</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div class="gem-c-metadata govuk-!-margin-bottom-3" data-module="gem-toggle metadata">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a class="govuk-link" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">Medicines and Healthcare products Regulatory Agency</a>

      </dd>
      <dt class="gem-c-metadata__term">Published</dt>
      <dd class="gem-c-metadata__definition">30 December 2020</dd>
      <dt class="gem-c-metadata__term">Last updated</dt>
      <dd class="gem-c-metadata__definition">
        7 September 2022
          — <a class="gem-c-metadata__definition-link govuk-!-display-none-print js-see-all-updates-link" data-track-action="see-all-updates-link-clicked" data-track-category="content-history" data-track-label="history" href="#full-publication-update-history">
            See all updates
          </a>
      </dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>

<div class="govuk-!-display-none-print govuk-!-margin-bottom-6" data-module="gem-track-click">
  <form action="/email/subscriptions/single-page/new" class="gem-c-single-page-notification-button" data-button-location="top" data-track-action="Subscribe-button-top" data-track-category="Single-page-notification-button" data-track-label="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca" method="POST">
    <input name="base_path" type="hidden" value="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca">
    <button class="govuk-body-s gem-c-single-page-notification-button__submit" type="submit">  <svg class="gem-c-single-page-notification-button__icon" height="18" viewBox="0 0 459.334 459.334" width="18" xmlns="http://www.w3.org/2000/svg"><path d="M177.216 404.514c-.001.12-.009.239-.009.359 0 30.078 24.383 54.461 54.461 54.461s54.461-24.383 54.461-54.461c0-.12-.008-.239-.009-.359H175.216zM403.549 336.438l-49.015-72.002v-89.83c0-60.581-43.144-111.079-100.381-122.459V24.485C254.152 10.963 243.19 0 229.667 0s-24.485 10.963-24.485 24.485v27.663c-57.237 11.381-100.381 61.879-100.381 122.459v89.83l-49.015 72.002a24.76 24.76 0 0 0 20.468 38.693H383.08a24.761 24.761 0 0 0 20.469-38.694z" fill="currentColor"></path></svg>Get emails about this page
</button>
</form>
</div>






<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    <div class="responsive-bottom-margin">
      

      <div class="responsive-bottom-margin">
          <section>
    <h2 class="gem-c-heading gem-c-heading--font-size-27 gem-c-heading--mobile-top-margin">Documents</h2>


      
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
        <section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca" tabindex="-1"><svg height="140" version="1.1" viewBox="0 0 99 140" width="99">
	<path d="M30,95h57v9H30V95z M30,77v9h39v-9H30z M30,122h48v-9H30V122z M12,68h9v-9h-9V68z M12,104h9v-9h-9V104z M12,86h9v-9h-9V86z   M12,122h9v-9h-9V122z M87,12v27H12V12H87z M33,17h-4v8h-6v-8h-4v18h4v-7l6,0v7l4,0V17z M49,17H35l0,3h5v15h4V20l5,0V17z M68,17h-4  l-5,6l-5-6h-4v18h4l0-12l5,6l5-6l0,12h4V17z M81,32h-6V17h-4v18h10V32z M30,68h57v-9H30V68z" stroke-width="0"></path>
</svg>
</a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca">Summary of Product Characteristics for Vaxzevria </a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1085916/uk-spc-vaxzevria-renewal_clean.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1085916/thumbnail_uk-spc-vaxzevria-renewal_clean.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1085916/uk-spc-vaxzevria-renewal_clean.pdf">Summary of Product Characteristics for Vaxzevria</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">289 KB</span>, <span class="page-length" lang="en">15 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/patient-information-leaflet-for-covid-19-vaccine-astrazeneca" tabindex="-1"><svg height="140" version="1.1" viewBox="0 0 99 140" width="99">
	<path d="M30,95h57v9H30V95z M30,77v9h39v-9H30z M30,122h48v-9H30V122z M12,68h9v-9h-9V68z M12,104h9v-9h-9V104z M12,86h9v-9h-9V86z   M12,122h9v-9h-9V122z M87,12v27H12V12H87z M33,17h-4v8h-6v-8h-4v18h4v-7l6,0v7l4,0V17z M49,17H35l0,3h5v15h4V20l5,0V17z M68,17h-4  l-5,6l-5-6h-4v18h4l0-12l5,6l5-6l0,12h4V17z M81,32h-6V17h-4v18h10V32z M30,68h57v-9H30V68z" stroke-width="0"></path>
</svg>
</a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/patient-information-leaflet-for-covid-19-vaccine-astrazeneca">Patient Information Leaflet for Vaxzevria </a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1085918/uk-pl-vaxzevria-renewal_clean.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1085918/thumbnail_uk-pl-vaxzevria-renewal_clean.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1085918/uk-pl-vaxzevria-renewal_clean.pdf">Patient Information Leaflet for Vaxzevria </a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">143 KB</span>, <span class="page-length" lang="en">7 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca--2" tabindex="-1"><svg height="140" version="1.1" viewBox="0 0 99 140" width="99">
	<path d="M30,95h57v9H30V95z M30,77v9h39v-9H30z M30,122h48v-9H30V122z M12,68h9v-9h-9V68z M12,104h9v-9h-9V104z M12,86h9v-9h-9V86z   M12,122h9v-9h-9V122z M87,12v27H12V12H87z M33,17h-4v8h-6v-8h-4v18h4v-7l6,0v7l4,0V17z M49,17H35l0,3h5v15h4V20l5,0V17z M68,17h-4  l-5,6l-5-6h-4v18h4l0-12l5,6l5-6l0,12h4V17z M81,32h-6V17h-4v18h10V32z M30,68h57v-9H30V68z" stroke-width="0"></path>
</svg>
</a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca--2">Conditions of Authorisation for Vaxzevria</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1006741/COVID-19_Vaccine_AstraZeneca_CMA_obligations_final_28_7_21.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1006741/thumbnail_COVID-19_Vaccine_AstraZeneca_CMA_obligations_final_28_7_21.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-6878367-accessibility-help" class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1006741/COVID-19_Vaccine_AstraZeneca_CMA_obligations_final_28_7_21.pdf">Conditions of Authorisation for Vaxzevria</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">51.2 KB</span>, <span class="page-length" lang="en">2 pages</span>
    </p>


      <div class="accessibility-warning" data-module="toggle">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary class="govuk-details__summary" data-details-track-click="" data-module="govuk-details" data-track-action="FormatRequestClicked" data-track-category="Accessible Format Request" data-track-label="Conditions of Authorisation for Vaxzevria">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Conditions%20of%20Authorisation%20for%20Vaxzevria%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Conditions%20of%20Authorisation%20for%20Vaxzevria%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/summary-of-the-public-assessment-report-par-for-vaxzevria" tabindex="-1"><svg height="140" version="1.1" viewBox="0 0 99 140" width="99">
	<path d="M30,95h57v9H30V95z M30,77v9h39v-9H30z M30,122h48v-9H30V122z M12,68h9v-9h-9V68z M12,104h9v-9h-9V104z M12,86h9v-9h-9V86z   M12,122h9v-9h-9V122z M87,12v27H12V12H87z M33,17h-4v8h-6v-8h-4v18h4v-7l6,0v7l4,0V17z M49,17H35l0,3h5v15h4V20l5,0V17z M68,17h-4  l-5,6l-5-6h-4v18h4l0-12l5,6l5-6l0,12h4V17z M81,32h-6V17h-4v18h10V32z M30,68h57v-9H30V68z" stroke-width="0"></path>
</svg>
</a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/summary-of-the-public-assessment-report-par-for-vaxzevria">Summary of the Public Assessment Report (PAR) for Vaxzevria</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1103097/CMA_UKPAR_COVID_19_Vaccine_AstraZeneca_PAR_16.07.2021.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1103097/thumbnail_CMA_UKPAR_COVID_19_Vaccine_AstraZeneca_PAR_16.07.2021.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-6878369-accessibility-help" class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1103097/CMA_UKPAR_COVID_19_Vaccine_AstraZeneca_PAR_16.07.2021.pdf">Public Assessment Report for Vaxzevria</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">1.08 MB</span>, <span class="page-length" lang="en">65 pages</span>
    </p>


      <div class="accessibility-warning" data-module="toggle">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary class="govuk-details__summary" data-details-track-click="" data-module="govuk-details" data-track-action="FormatRequestClicked" data-track-category="Accessible Format Request" data-track-label="Public Assessment Report for Vaxzevria">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Public%20Assessment%20Report%20for%20Vaxzevria%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Public%20Assessment%20Report%20for%20Vaxzevria%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174" tabindex="-1"><svg height="140" version="1.1" viewBox="0 0 99 140" width="99">
	<path d="M30,95h57v9H30V95z M30,77v9h39v-9H30z M30,122h48v-9H30V122z M12,68h9v-9h-9V68z M12,104h9v-9h-9V104z M12,86h9v-9h-9V86z   M12,122h9v-9h-9V122z M87,12v27H12V12H87z M33,17h-4v8h-6v-8h-4v18h4v-7l6,0v7l4,0V17z M49,17H35l0,3h5v15h4V20l5,0V17z M68,17h-4  l-5,6l-5-6h-4v18h4l0-12l5,6l5-6l0,12h4V17z M81,32h-6V17h-4v18h10V32z M30,68h57v-9H30V68z" stroke-width="0"></path>
</svg>
</a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174">ARCHIVE: Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1059210/uk-clean-spc-covid-19-vaccine-astrazeneca-reg174_-_26-01-2022.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1059210/thumbnail_uk-clean-spc-covid-19-vaccine-astrazeneca-reg174_-_26-01-2022.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1059210/uk-clean-spc-covid-19-vaccine-astrazeneca-reg174_-_26-01-2022.pdf">ARCHIVE: Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">189 KB</span>, <span class="page-length" lang="en">16 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-uk-recipients-on-covid-19-vaccine-astrazeneca" tabindex="-1"><svg height="140" version="1.1" viewBox="0 0 99 140" width="99">
	<path d="M30,95h57v9H30V95z M30,77v9h39v-9H30z M30,122h48v-9H30V122z M12,68h9v-9h-9V68z M12,104h9v-9h-9V104z M12,86h9v-9h-9V86z   M12,122h9v-9h-9V122z M87,12v27H12V12H87z M33,17h-4v8h-6v-8h-4v18h4v-7l6,0v7l4,0V17z M49,17H35l0,3h5v15h4V20l5,0V17z M68,17h-4  l-5,6l-5-6h-4v18h4l0-12l5,6l5-6l0,12h4V17z M81,32h-6V17h-4v18h10V32z M30,68h57v-9H30V68z" stroke-width="0"></path>
</svg>
</a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-uk-recipients-on-covid-19-vaccine-astrazeneca">ARCHIVE: Information for UK recipients on COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1059211/uk-clean-pl-covid-19-vaccine-astrazeneca-reg174_-_26-01-2022.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1059211/thumbnail_uk-clean-pl-covid-19-vaccine-astrazeneca-reg174_-_26-01-2022.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1059211/uk-clean-pl-covid-19-vaccine-astrazeneca-reg174_-_26-01-2022.pdf">ARCHIVE: Information for UK recipients on COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">147 KB</span>, <span class="page-length" lang="en">8 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca" tabindex="-1"><svg height="140" version="1.1" viewBox="0 0 99 140" width="99">
	<path d="M30,95h57v9H30V95z M30,77v9h39v-9H30z M30,122h48v-9H30V122z M12,68h9v-9h-9V68z M12,104h9v-9h-9V104z M12,86h9v-9h-9V86z   M12,122h9v-9h-9V122z M87,12v27H12V12H87z M33,17h-4v8h-6v-8h-4v18h4v-7l6,0v7l4,0V17z M49,17H35l0,3h5v15h4V20l5,0V17z M68,17h-4  l-5,6l-5-6h-4v18h4l0-12l5,6l5-6l0,12h4V17z M81,32h-6V17h-4v18h10V32z M30,68h57v-9H30V68z" stroke-width="0"></path>
</svg>
</a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca">ARCHIVE: Conditions of Authorisation for COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016207/AZ_Conditions__-_9SEPT21.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016207/thumbnail_AZ_Conditions__-_9SEPT21.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016207/AZ_Conditions__-_9SEPT21.pdf">ARCHIVE: Conditions of Authorisation for COVID-19 Vaccine AstraZeneca (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">267 KB</span>, <span class="page-length" lang="en">11 pages</span>
    </p>


  </div>
</section>

</div>
  </section>


        <section>
          <h2 class="gem-c-heading gem-c-heading--font-size-27 gem-c-heading--mobile-top-margin">Details</h2>


          
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
            <div class="govspeak">
<p>On 24 June 2021, the <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> issued a Conditional Marketing Authorisation (<abbr title="Conditional Marketing Authorisation">CMA</abbr>) for COVID-19 Vaccine AstraZeneca in Great Britain (GB).  A <abbr title="Conditional Marketing Authorisation">CMA</abbr> issued by the European Medicines Agency has had effect in Northern Ireland since 29 January 2021. To date, supply of the AstraZeneca vaccine in the UK has been authorised on a temporary basis by the <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> under Regulation 174 of the Human Medicine Regulations 2012, but as this was always intended to be a temporary arrangement, supply of this vaccine will change to be in accordance with the CMAs.</p>

<p>Manufacture of the vaccine remains unchanged, as do the clinical, pharmacological and pharmaceutical properties of the vaccine.</p>

<p>The information for healthcare professionals and UK recipients on using the vaccine safely has been periodically updated as new data have become available and this will continue under the <abbr title="Conditional Marketing Authorisation">CMA</abbr>. Please regularly check this information as it is often updated.</p>

<p>The COVID-19 Vaccine AstraZeneca authorised under Regulation 174 remains in use and its product information has been updated in line with the product information of the GB <abbr title="Conditional Marketing Authorisation">CMA</abbr>.</p>

<p>The <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> regularly publishes <a class="govuk-link" href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.gov.uk_government_publications_coronavirus-2Dcovid-2D19-2Dvaccine-2Dadverse-2Dreactions_coronavirus-2Dvaccine-2Dsummary-2Dof-2Dyellow-2Dcard-2Dreporting&amp;d=DwMFAw&amp;c=bXyEFqpHx20PVepeYtwgeyo6Hxa8iNFcGZACCQj1uNM&amp;r=RwY7gBVRFs7-J0I18jj3IoNV0FzvgEDZFBhtsTaYQtg&amp;m=EGsoy2Cpn4g8e77CUQnm1MpA2mn8TX0lqxp_PRUsdcs&amp;s=aIVqJ9ajG7JDJKKrAQY7D_vOycpVnt_X7zGVWwkrXf8&amp;e=" rel="external">reports of the safety of the COVID-19 vaccines</a>.</p>

<p>For further information on prioritising the first COVID-19 vaccine dose see the <a class="govuk-link" href="https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement">statement from the Joint Committee on Vaccination and Immunisation (JCVI).</a></p>

<h3>Summary of Product Characteristics (<abbr title="Conditional Marketing Authorisation">CMA</abbr>)/Information for Healthcare Professionals (R174)</h3>
<p>This is a description of a medicinal product’s properties and the conditions attached to its use. It explains how to use and prescribe a medicine. It is used by healthcare professionals, such as doctors, nurses and pharmacists.</p>

<h3>Patient Information Leaflet (<abbr title="Conditional Marketing Authorisation">CMA</abbr>)/Information for UK Recipients (R174)</h3>
<p>The Patient Information Leaflet provides information for patients on using the medicine safely. This is based on the Summary of Product Characteristics of the product.</p>

<h3>Public Assessment Report</h3>

<p>The Public Assessment Report (<abbr title="Public Assessment Report">PAR</abbr>) is a scientific report, written by the <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr>. It explains how this product was assessed and how its authorisation was recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use this product.</p>

<h2>Ingredients</h2>

<p>The <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> can confirm that COVID-19 Vaccine AstraZeneca does not contain any components of animal origin.</p>

<p>A full list of ingredients for the qualitative and quantitative composition of the vaccine can be found at point 2 in the <a class="govuk-link" href="https://draft-origin.publishing.service.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca" rel="external">Summary of Product Characteristics</a> (<abbr title="Conditional Marketing Authorisation">CMA</abbr>) and the <a class="govuk-link" href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174">Information for Healthcare Professionals</a> (R174).</p>

<p>A full list of ingredients for the excipient composition of the vaccine can be found at point 6.1 in the <a class="govuk-link" href="https://draft-origin.publishing.service.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca" rel="external">Summary of Product Characteristics</a> (<abbr title="Conditional Marketing Authorisation">CMA</abbr>) and the <a class="govuk-link" href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174">Information for Healthcare Professionals</a> (R174).</p>

<p>A full list of ingredients for the qualitative and quantitative composition of the vaccine and a full list of the excipient composition of the vaccine can be found at point 6 in the <a class="govuk-link" href="https://draft-origin.publishing.service.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca" rel="external">Summary of Product Characteristics</a> (<abbr title="Conditional Marketing Authorisation">CMA</abbr>) and the <a class="govuk-link" href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174">Information for Healthcare Professionals</a> (R174).</p>

</div>

</div>
        </section>
      </div>
      
<div class="app-c-published-dates app-c-published-dates--history govuk-!-margin-bottom-3" data-module="gem-toggle" lang="en">
    Published 30 December 2020
    <br>Last updated 7 September 2022
      <a class="app-c-published-dates__toggle govuk-link" data-controls="full-history" data-expanded="false" data-toggled-text="-&nbsp;hide all updates" href="#full-history">+&nbsp;show all updates</a>
      <div class="app-c-published-dates__change-history js-hidden">
        <ol class="app-c-published-dates__list">
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2022-09-07T17:01:03.000+01:00">7 September 2022</time>
              <p class="app-c-published-dates__change-note">Updated the HTML and PDF versions of the Public Assessment Report</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2022-06-27T14:09:22.000+01:00">27 June 2022</time>
              <p class="app-c-published-dates__change-note">Renewal of the conditional marketing authorisation
Updated efficacy and immunogenicity data (SPC section 5.1)
Updated preclinical data (SPC sections 4.6 and 5.3 and package leaflet information)
Updated frequency of thrombocytopenia (SPC section 4.8 and package leaflet information)</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2022-01-26T15:15:46.000+00:00">26 January 2022</time>
              <p class="app-c-published-dates__change-note">SPC updated: Neurological Events section:

Extremely rare cases of transverse myelitis have been reported following Vaxzevria. A further dose of Vaxzevria should not be given to those who have experienced symptoms of transverse myelitis after a previous dose of this vaccine

PIL Updated: Transverse Myelitis (inflammation of the spinal cord) added to "warnings and precautions" 

"Not Known" side effect added: inflammation of the spinal cord which may cause muscle weakness, localised or radiating back pain, bladder and bowel symptoms and changes in sensation (transverse myelitis)</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2022-01-05T14:42:33.000+00:00">5 January 2022</time>
              <p class="app-c-published-dates__change-note">Updated the Reg 174 information for Healthcare professionals and UK recipients</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2022-01-05T12:54:33.000+00:00">5 January 2022</time>
              <p class="app-c-published-dates__change-note">Updated summary of product characteristics and package leaflet information for Vaxzevria</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-10-21T11:12:06.000+01:00">21 October 2021</time>
              <p class="app-c-published-dates__change-note">Added Guillain-Barré syndrome [GBS] as a very rare side effect.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-10-19T10:00:12.000+01:00">19 October 2021</time>
              <p class="app-c-published-dates__change-note">Updated information for healthcare professionals and for patients</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-09-09T07:01:18.000+01:00">9 September 2021</time>
              <p class="app-c-published-dates__change-note">Updated sections of Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca (Regulation 174) and Information for UK recipients on COVID-19 Vaccine AstraZeneca (Regulation 174) to include information about receiving a third dose. Also updated the Regulation 174 Conditions document with additional pharmacovigilance conditions.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-08-20T18:40:23.000+01:00">20 August 2021</time>
              <p class="app-c-published-dates__change-note">Updated the PIL and Spc to include new warning on Guillaine-Barre Syndrome</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-07-19T15:16:28.000+01:00">19 July 2021</time>
              <p class="app-c-published-dates__change-note">Added Lay summary, Vaxzevria (previously COVID‑19 Vaccine AstraZeneca, suspension for injection) COVID-19 Vaccine (ChAdOx1‑S [recombinant])</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-07-16T17:25:58.000+01:00">16 July 2021</time>
              <p class="app-c-published-dates__change-note">Updated to reflect the addition of capillary leak syndrome as a contraindication. Also changed the name of the COVID-19 Vaccine AstraZeneca in the Conditional Marketing Authorisation product information to the brand name - Vaxzevria.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-06-25T07:02:50.000+01:00">25 June 2021</time>
              <p class="app-c-published-dates__change-note">A Summary of Product Information, a Patient Information Leaflet and a Conditions of Authorisation for COVID-19 Vaccine AstraZeneca Conditional Marketing Authorisation have been added as the MHRA has issued a Conditional Marketing Authorisation for the vaccine. Updated versions of the Information for healthcare professionals and Information for UK recipients documents have also been added.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-04-15T15:24:12.000+01:00">15 April 2021</time>
              <p class="app-c-published-dates__change-note">Updated the Information for Healthcare Professionals and Information for UK Recipients on COVID-19 Vaccine AstraZeneca with new information about extremely rare, unlikely to occur blood clots.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-04-07T16:23:40.000+01:00">7 April 2021</time>
              <p class="app-c-published-dates__change-note">Updated the Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca, with new information about extremely rare, unlikely to occur blood clots.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-02-23T14:45:28.000+00:00">23 February 2021</time>
              <p class="app-c-published-dates__change-note">All documents were updated to include updated side effect frequency and efficacy data, including a new table on efficacy by dosing interval in the Information for UK Healthcare Professionals document. A new Annex (Annex 1: Addition of manufacturer and importer) was added to the Conditions of Authorisation document.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-01-28T11:45:07.000+00:00">28 January 2021</time>
              <p class="app-c-published-dates__change-note">Published new versions of the Conditions of Authorisation documents, with an additional clause relating to off-label prescribing</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-01-07T15:13:32.000+00:00">7 January 2021</time>
              <p class="app-c-published-dates__change-note">Published a new version of the Information for UK healthcare professionals, adding new information in Section 6.6 allowing for an additional dose to be taken if there is sufficient for a further full dose to be taken from the vial.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-01-06T12:15:29.000+00:00">6 January 2021</time>
              <p class="app-c-published-dates__change-note">Added an accessible HTML version of the summary of the Public Assessment Report</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-01-05T16:13:38.000+00:00">5 January 2021</time>
              <p class="app-c-published-dates__change-note">Publication of Public Assessment Report for AztraZeneca COVID-19 vaccine</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-12-30T10:47:00.000+00:00">30 December 2020</time>
              <p class="app-c-published-dates__change-note">First published.</p>
            </li>
        </ol>
      </div>
</div>

<div class="govuk-!-display-none-print govuk-!-margin-bottom-0" data-module="gem-track-click">
  <form action="/email/subscriptions/single-page/new" class="gem-c-single-page-notification-button" data-button-location="bottom" data-track-action="Subscribe-button-bottom" data-track-category="Single-page-notification-button" data-track-label="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca" method="POST">
    <input name="base_path" type="hidden" value="/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca">
    <button class="govuk-body-s gem-c-single-page-notification-button__submit" type="submit">  <svg class="gem-c-single-page-notification-button__icon" height="18" viewBox="0 0 459.334 459.334" width="18" xmlns="http://www.w3.org/2000/svg"><path d="M177.216 404.514c-.001.12-.009.239-.009.359 0 30.078 24.383 54.461 54.461 54.461s54.461-24.383 54.461-54.461c0-.12-.008-.239-.009-.359H175.216zM403.549 336.438l-49.015-72.002v-89.83c0-60.581-43.144-111.079-100.381-122.459V24.485C254.152 10.963 243.19 0 229.667 0s-24.485 10.963-24.485 24.485v27.663c-57.237 11.381-100.381 61.879-100.381 122.459v89.83l-49.015 72.002a24.76 24.76 0 0 0 20.468 38.693H383.08a24.761 24.761 0 0 0 20.469-38.694z" fill="currentColor"></path></svg>Get emails about this page
</button>
</form>
</div>

    </div>
  </div>
  
<div class="govuk-grid-column-one-third">
  


</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav class="gem-c-related-navigation__nav-section" data-module="gem-toggle" role="navigation">

    <h2 class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="gem-track-click">


        <li class="gem-c-related-navigation__link"><a class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-action="1.1 Explore the topic" data-track-category="relatedLinkClicked" data-track-label="/health-and-social-care/pharmacy" data-track-options="{&quot;dimension28&quot;:&quot;2&quot;,&quot;dimension29&quot;:&quot;Pharmacy&quot;}" href="/health-and-social-care/pharmacy">Pharmacy</a></li>
        <li class="gem-c-related-navigation__link"><a class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-action="1.2 Explore the topic" data-track-category="relatedLinkClicked" data-track-label="/coronavirus-taxon/vaccinations" data-track-options="{&quot;dimension28&quot;:&quot;2&quot;,&quot;dimension29&quot;:&quot;Vaccinations for coronavirus&quot;}" href="/coronavirus-taxon/vaccinations">Vaccinations for coronavirus</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>